Large-scale randomised controlled trials comparing recovery times between children with a variety of infections receiving different antipyretics and a placebo would help illuminate this aspect, although recruitment to such a trial might be dif cult based on the popularity of antipyretics. Other areas that might bene t from greater investigation include how parental anxiety can be reduced, factors that predispose to toxicity and how these drugs can be most safely packaged and used.